Legal Alert: Senate Approves Bill to Increase Regulatory Powers of FDA

The user fee arrangement currently in effect between industry and the government, which provides the Food & Drug Administration ("FDA") approximately half of the funding for drug review and approval, is scheduled to expire on September 30, 2007. Commentators refer to the renewal of this arrangement as a "must pass" because if Congress fails to act by summer, FDA could be forced to notify hundreds of senior scientists, doctors and statisticians, whose skills are in demand in the private industry, that their jobs might be at risk.

Download the File